Clinical Trial Update: Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years. [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting safety and immunological efficacy of the pentavalent rotavirus vaccine Rota-V-Aid in healthy adults aged 18-45; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infections

Drugs mentioned

• Rota-V-Aid (unknown)

Snippet

Sponsor: Limited Liability Company Pharm Aid | Conditions: Rotavirus Infections, Rotavirus Vaccines | Phase 3 | Status: COMPLETED